Dr. Robert Clark, MD

NPI: 1033372727
Total Payments
$13,314
2024 Payments
$2,438
Companies
42
Transactions
670
Medicare Patients
3,918
Medicare Billing
$949,256

Payment Breakdown by Category

Food & Beverage$13,151 (98.8%)
Education$88.41 (0.7%)
Gifts$74.46 (0.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,151 656 98.8%
Education $88.41 6 0.7%
Gift $74.46 4 0.6%
Unspecified $0 4 0.0%

Payments by Type

General
$13,314
666 transactions
Ownership
$0
4 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $4,698 213 $0 (2024)
Janssen Biotech, Inc. $1,679 117 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,151 64 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $688.27 39 $0 (2024)
Celgene Corporation $403.05 24 $0 (2024)
PFIZER INC. $389.66 21 $0 (2024)
Regeneron Healthcare Solutions, Inc. $381.37 14 $0 (2024)
E.R. Squibb & Sons, L.L.C. $371.33 3 $0 (2024)
Synergy Pharmaceuticals Inc $291.43 16 $0 (2018)
Gilead Sciences, Inc. $282.84 9 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,438 128 ABBVIE INC. ($749.44)
2023 $2,879 140 AbbVie Inc. ($973.43)
2022 $1,998 97 ABBVIE INC. ($794.37)
2021 $707.64 30 AbbVie Inc. ($219.86)
2020 $375.32 21 AbbVie Inc. ($123.10)
2019 $1,629 75 AbbVie, Inc. ($560.40)
2018 $1,729 92 AbbVie, Inc. ($811.80)
2017 $1,557 87 AbbVie, Inc. ($465.58)

All Payment Transactions

670 individual payment records from CMS Open Payments — Page 1 of 27

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.34 General
Category: Gastroenterology
12/17/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $17.07 General
Category: INTERNAL MEDICINE
12/12/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $30.49 General
Category: INFLAMMATION AND IMMUNOLOGY
12/12/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $5.03 General
Category: IMMUNOLOGY
12/11/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $17.42 General
Category: GI
12/04/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.48 General
Category: GASTROENTEROLOGY
11/14/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $18.99 General
Category: IMMUNOLOGY
11/14/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $1.73 General
Category: IMMUNOLOGY
11/13/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $19.67 General
Category: IMMUNOLOGY
11/13/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $2.03 General
Category: IMMUNOLOGY
11/11/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.97 General
Category: Immunology
11/11/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $8.03 General
Category: IMMUNOLOGY
11/07/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $21.18 General
Category: Immunology
11/07/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $2.04 General
Category: Immunology
11/04/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $9.19 General
Category: GI
11/01/2024 Sandoz Inc. HYRIMOZ (Biological) Food and Beverage In-kind items and services $27.72 General
Category: Immunology
10/29/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $22.85 General
Category: IMMUNOLOGY
10/22/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.56 General
Category: Gastroenterology
10/22/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $15.42 General
Category: INTERNAL MEDICINE
10/21/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $1.50 General
Category: IMMUNOLOGY
10/20/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.41 General
Category: IMMUNOLOGY
10/14/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $27.62 General
Category: Immunology
10/14/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $3.64 General
Category: Immunology
10/10/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.62 General
Category: Immunology
10/05/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $21.25 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 899 7,603 $1.1M $218,124
2022 15 977 7,125 $1.0M $201,634
2021 18 1,140 10,922 $1.1M $280,082
2020 17 902 10,683 $929,097 $249,416
Total Patients
3,918
Total Services
36,333
Medicare Billing
$949,256
Procedure Codes
62

All Medicare Procedures & Services

62 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J3380 Injection, vedolizumab, 1 mg Office 2023 11 6,607 $330,000 $113,167 34.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 140 141 $200,925 $29,143 14.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 243 245 $304,995 $25,690 8.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 162 229 $34,350 $13,848 40.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 84 98 $20,776 $8,512 41.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 99 104 $96,175 $6,998 7.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 36 36 $50,968 $6,497 12.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 44 44 $14,432 $5,002 34.7%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 43 43 $31,175 $4,817 15.5%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 11 11 $13,090 $1,611 12.3%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 13 31 $4,526 $1,448 32.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 13 14 $4,200 $1,393 33.2%
J3380 Injection, vedolizumab, 1 mg Office 2022 13 6,010 $282,000 $99,655 35.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 116 118 $169,262 $23,133 13.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 210 210 $261,172 $20,703 7.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 183 252 $38,043 $14,380 37.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 107 125 $26,695 $11,177 41.9%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 112 118 $105,543 $8,607 8.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 52 52 $17,056 $5,754 33.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 22 22 $31,277 $3,991 12.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 37 38 $11,772 $3,824 32.5%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2022 30 31 $23,154 $3,314 14.3%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 31 60 $8,840 $1,817 20.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 23 23 $5,650 $1,503 26.6%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2022 14 34 $5,984 $1,470 24.6%

About Dr. Robert Clark, MD

Dr. Robert Clark, MD is a Internal Medicine healthcare provider based in Bloomington, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033372727.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Clark, MD has received a total of $13,314 in payments from pharmaceutical and medical device companies, with $2,438 received in 2024. These payments were reported across 670 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($13,151).

As a Medicare-enrolled provider, Clark has provided services to 3,918 Medicare beneficiaries, totaling 36,333 services with total Medicare billing of $949,256. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology, Gastroenterology
  • Location Bloomington, IL
  • Active Since 07/03/2008
  • Last Updated 06/28/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1033372727

Products in Payments

  • RINVOQ (Biological) $1,273
  • Humira (Biological) $1,251
  • STELARA (Biological) $1,098
  • SKYRIZI (Biological) $758.35
  • XIFAXAN (Drug) $741.99
  • ZEPOSIA (Drug) $615.76
  • ENTYVIO (Biological) $582.69
  • DUPIXENT (Biological) $567.53
  • Entyvio (Biological) $538.13
  • REMICADE (Biological) $438.10
  • LINZESS (Drug) $367.41
  • HUMIRA (Biological) $359.63
  • XELJANZ (Drug) $347.69
  • TREMFYA (Drug) $300.77
  • Trulance (Drug) $291.43
  • Cimzia (Drug) $265.86
  • Epclusa (Drug) $204.53
  • ZENPEP (Drug) $170.08
  • VIBERZI (Drug) $163.88
  • IBSRELA (Drug) $143.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Bloomington